<DOC>
	<DOC>NCT00814528</DOC>
	<brief_summary>The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil (5-FU).</brief_summary>
	<brief_title>Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>1895 years old Diagnosied with actinic keratoses. Patients who have had Isotretinoin therapy less that 1 year prior to screening. Patients who have an adverse reaction to light exposure (for example photo exacerbated seizures). History of porphyria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>actinic keratosis</keyword>
	<keyword>skin lesions</keyword>
	<keyword>5-ALA</keyword>
	<keyword>AK</keyword>
	<keyword>Blu-Light</keyword>
</DOC>